141 related articles for article (PubMed ID: 11131990)
1. Phenotypic change of human cultured meningioma cells.
Pallini R; Casalbore P; Mercanti D; Maggiano N; Larocca LM
J Neurooncol; 2000 Aug; 49(1):9-17. PubMed ID: 11131990
[TBL] [Abstract][Full Text] [Related]
2. Expression of beta2 integrins and macrophage-associated antigens in meningeal tumours.
Mosnier JF; Perret AG; Scoazec JY; Brunon J
Virchows Arch; 2000 Feb; 436(2):131-7. PubMed ID: 10755603
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma.
Kanno H; Nishihara H; Wang L; Yuzawa S; Kobayashi H; Tsuda M; Kimura T; Tanino M; Terasaka S; Tanaka S
Neuro Oncol; 2013 Jul; 15(7):853-64. PubMed ID: 23539121
[TBL] [Abstract][Full Text] [Related]
4. Evidence of ubiquitous in vivo and in vitro expression of pro-apoptotic Smac/DIABLO protein in meningioma cell lines.
Pfister C; Ritz R; Endemann E; Schittenhelm J; Bornemann A; Tatagiba MS; Roser F
Oncol Rep; 2009 May; 21(5):1181-8. PubMed ID: 19360292
[TBL] [Abstract][Full Text] [Related]
5. CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro.
Bajetto A; Barbieri F; Pattarozzi A; Dorcaratto A; Porcile C; Ravetti JL; Zona G; Spaziante R; Schettini G; Florio T
Neuro Oncol; 2007 Jan; 9(1):3-11. PubMed ID: 17108064
[TBL] [Abstract][Full Text] [Related]
6. Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas.
Tonn JC; Ott MM; Bouterfa H; Kerkau S; Kapp M; Müller-Hermelink HK; Roosen K
Neurosurgery; 1997 Nov; 41(5):1152-9. PubMed ID: 9361071
[TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical study of mononuclear cells in meningiomas.
Bø L; Mørk SJ; Nyland H
Neuropathol Appl Neurobiol; 1992 Dec; 18(6):548-58. PubMed ID: 1488087
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence automatic cell sorter and immunohistochemical investigation of CD68-positive cells in meningioma.
Asai J; Suzuki R; Fujimoto T; Suzuki T; Nakagawa N; Nagashima G; Miyo T; Hokaku H; Takei A
Clin Neurol Neurosurg; 1999 Dec; 101(4):229-34. PubMed ID: 10622450
[TBL] [Abstract][Full Text] [Related]
9. CD68 and CR3/43 immunohistochemical expression in secretory meningiomas.
Caffo M; Caruso G; Germanò A; Galatioto S; Meli F; Tomasello F
Neurosurgery; 2005 Sep; 57(3):551-7; discussion 551-7. PubMed ID: 16145535
[TBL] [Abstract][Full Text] [Related]
10. Secretory meningioma: clinical, histologic, and immunohistochemical findings in 31 cases.
Probst-Cousin S; Villagran-Lillo R; Lahl R; Bergmann M; Schmid KW; Gullotta F
Cancer; 1997 May; 79(10):2003-15. PubMed ID: 9149029
[TBL] [Abstract][Full Text] [Related]
11. Meningiomas. An immunohistochemical study of 50 cases.
Meis JM; Ordóñez NG; Bruner JM
Arch Pathol Lab Med; 1986 Oct; 110(10):934-7. PubMed ID: 2429637
[TBL] [Abstract][Full Text] [Related]
12. Lipoblastic meningioma: "vacuolated meningioma".
Lattes R; Bigotti G
Hum Pathol; 1991 Feb; 22(2):164-71. PubMed ID: 2001878
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of anaplastic meningioma with special reference to the phenotypic change of intermediate filament protein.
Ikeda H; Yoshimoto T
Ann Diagn Pathol; 2003 Aug; 7(4):214-22. PubMed ID: 12913843
[TBL] [Abstract][Full Text] [Related]
14. Metabolic aggressiveness in benign meningiomas with chromosomal instabilities.
Monleón D; Morales JM; Gonzalez-Segura A; Gonzalez-Darder JM; Gil-Benso R; Cerdá-Nicolás M; López-Ginés C
Cancer Res; 2010 Nov; 70(21):8426-34. PubMed ID: 20861191
[TBL] [Abstract][Full Text] [Related]
15. Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma.
Patel KS; Kejriwal S; Sun MM; Thammachantha S; Duong C; Chan A; Cherian N; Romiyo P; Gordon LK; Yong W; Wadehra M; Yang I
J Neurooncol; 2020 Mar; 147(1):15-24. PubMed ID: 31981014
[TBL] [Abstract][Full Text] [Related]
16. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
17. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
Barresi V; Cerasoli S; Vitarelli E; Tuccari G
Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
[TBL] [Abstract][Full Text] [Related]
18. miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas.
Shi L; Jiang D; Sun G; Wan Y; Zhang S; Zeng Y; Pan T; Wang Z
J Neurooncol; 2012 Nov; 110(2):155-62. PubMed ID: 22886530
[TBL] [Abstract][Full Text] [Related]
19. The transmembrane chemokines CXCL16 and CX3CL1 and their receptors are expressed in human meningiomas.
Li G; Hattermann K; Mentlein R; Mehdorn HM; Held-Feindt J
Oncol Rep; 2013 Feb; 29(2):563-70. PubMed ID: 23229614
[TBL] [Abstract][Full Text] [Related]
20. KLF4 is a tumor suppressor in anaplastic meningioma stem-like cells and human meningiomas.
Tang H; Zhu H; Wang X; Hua L; Li J; Xie Q; Chen X; Zhang T; Gong Y
J Mol Cell Biol; 2017 Aug; 9(4):315-324. PubMed ID: 28651379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
